{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:05:42Z","timestamp":1784610342022,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R18HS029348"],"award-info":[{"award-number":["R18HS029348"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05348-2","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:22:02Z","timestamp":1768198922000},"page":"4000-4007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting high-grade clinically significant prostate cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Ronilda","family":"Lacson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Kikano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Haj-Mirzaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Khorasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"5348_CR1","unstructured":"American Cancer Society. Key Statistics for Prostate Cancer. Last accessed March 4, 2025. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html. 2025."},{"issue":"4","key":"5348_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746\u201357. doi:https:\/\/doi.org\/10.1007\/s00330-011-2377-y","journal-title":"Eur Radiol"},{"key":"5348_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.052","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69(1):16\u201340. doi:https:\/\/doi.org\/10.1016\/j.eururo.2015.08.052"},{"issue":"2","key":"5348_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019182946","volume":"292","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Barentsz J, Villeirs G, et al. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology. 2019;292(2):464\u2013474. doi:https:\/\/doi.org\/10.1148\/radiol.2019182946","journal-title":"Radiology"},{"issue":"4","key":"5348_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/JU.0000000000000617","volume":"203","author":"MA Bjurlin","year":"2020","unstructured":"Bjurlin MA, Carroll PR, Eggener S, et al. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. Apr 2020;203(4):706\u2013712. doi:https:\/\/doi.org\/10.1097\/JU.0000000000000617","journal-title":"J Urol. Apr"},{"issue":"10","key":"5348_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE, et al. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. N Engl J Med. 2020;382(10):917\u2013928. doi:https:\/\/doi.org\/10.1056\/NEJMoa1910038","journal-title":"N Engl J Med"},{"issue":"3","key":"5348_CR7","doi-asserted-by":"publisher","first-page":"e244258","DOI":"10.1001\/jamanetworkopen.2024.4258","volume":"7","author":"A Haj-Mirzaian","year":"2024","unstructured":"Haj-Mirzaian A, Burk KS, Lacson R, et al. Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7(3):e244258. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4258","journal-title":"JAMA Netw Open"},{"issue":"7","key":"5348_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacr.2023.02.034","volume":"20","author":"KS Burk","year":"2023","unstructured":"Burk KS, Naik S, Lacson R, et al. MRI-Targeted, Systematic, or Combined Biopsy for Detecting Clinically Significant Prostate Cancer. J Am Coll Radiol. 2023;20(7):687\u2013695. doi:https:\/\/doi.org\/10.1016\/j.jacr.2023.02.034","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"5348_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020;296(1):76\u201384. doi:https:\/\/doi.org\/10.1148\/radiol.2020190646","journal-title":"Radiology"},{"issue":"3","key":"5348_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E, et al. Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. Eur Urol. 2020;78(3):402\u2013414. doi:https:\/\/doi.org\/10.1016\/j.eururo.2020.03.048","journal-title":"Eur Urol"},{"issue":"2","key":"5348_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.eururo.2018.07.031","volume":"75","author":"AR Alberts","year":"2019","unstructured":"Alberts AR, Roobol MJ, Verbeek JFM, et al. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators. Eur Urol. 2019;75(2):310\u2013318. doi:https:\/\/doi.org\/10.1016\/j.eururo.2018.07.031","journal-title":"Eur Urol"},{"key":"5348_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.urology.2018.12.010","volume":"126","author":"NR Bhat","year":"2019","unstructured":"Bhat NR, Vetter JM, Andriole GL, Shetty AS, Ippolito JE, Kim EH. Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy. Urology. 2019;126:152\u2013157. doi:https:\/\/doi.org\/10.1016\/j.urology.2018.12.010","journal-title":"Urology"},{"issue":"1","key":"5348_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12957-023-02959-1","volume":"21","author":"Z Ma","year":"2023","unstructured":"Ma Z, Wang X, Zhang W, et al. Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI. World J Surg Oncol. 2023;21(1):83. doi:https:\/\/doi.org\/10.1186\/s12957-023-02959-1","journal-title":"World J Surg Oncol"},{"issue":"2","key":"5348_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024;86(2):148\u2013163. doi:https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"issue":"2","key":"5348_CR15","doi-asserted-by":"publisher","first-page":"e0315979","DOI":"10.1371\/journal.pone.0315979","volume":"20","author":"A Beltr\u00e1n","year":"2025","unstructured":"Beltr\u00e1n A, Parker L, Moral-P\u00e9rez I, et al. Impact of patients\u2019 age and comorbidities on prostate cancer overdiagnosis in clinical practice. PLoS One. 2025;20(2):e0315979. doi:https:\/\/doi.org\/10.1371\/journal.pone.0315979","journal-title":"PLoS One"},{"key":"5348_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2024.02.035","author":"R Lacson","year":"2024","unstructured":"Lacson R, Haj-Mirzaian A, Burk K, et al. A Model for Predicting Clinically Significant Prostate Cancer Using Prostate MRI and Risk Factors. J Am Coll Radiol. 2024;doi:https:\/\/doi.org\/10.1016\/j.jacr.2024.02.035","journal-title":"J Am Coll Radiol"},{"key":"5348_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.euros.2025.01.012","volume":"72","author":"R Leni","year":"2025","unstructured":"Leni R, Vertosick EA, Liso N, et al. Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management. Eur Urol Open Sci. 2025;72:46\u201353. doi:https:\/\/doi.org\/10.1016\/j.euros.2025.01.012","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"5348_CR18","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/JU.0000000000000742","volume":"203","author":"S Carlsson","year":"2020","unstructured":"Carlsson S, Benfante N, Alvim R, et al. Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center. J Urol. 2020;203(6):1117\u20131121. doi:https:\/\/doi.org\/10.1097\/JU.0000000000000742","journal-title":"J Urol"},{"issue":"1","key":"5348_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA\/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management. J Urol. 2022;208(1):10\u201318. doi:https:\/\/doi.org\/10.1097\/JU.0000000000002757","journal-title":"J Urol"},{"issue":"2","key":"5348_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243\u2013262. doi:https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042","journal-title":"Eur Urol"},{"key":"5348_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. doi:https:\/\/doi.org\/10.1186\/1751-0473-3-17","journal-title":"Source Code Biol Med"},{"issue":"10","key":"5348_CR22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/sim.1742","volume":"23","author":"LM Sullivan","year":"2004","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004;23(10):1631\u201360. doi:https:\/\/doi.org\/10.1002\/sim.1742","journal-title":"Stat Med"},{"issue":"8","key":"5348_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jnci\/djj131","volume":"98","author":"IM Thompson","year":"2006","unstructured":"Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006;98(8):529\u201334. doi:https:\/\/doi.org\/10.1093\/jnci\/djj131","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5348_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. doi:https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"5348_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/j.1538-7836.2008.02944.x","volume":"6","author":"JA Kline","year":"2008","unstructured":"Kline JA, Courtney DM, Kabrhel C, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008;6(5):772\u201380. doi:https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02944.x","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5348_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0037-1613830","volume":"83","author":"PS Wells","year":"2000","unstructured":"Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83(3):416\u201320.","journal-title":"Thromb Haemost"},{"key":"5348_CR27","doi-asserted-by":"publisher","unstructured":"Simforoosh N, Dadpour M, Narouie B, Madani MH. Active surveillance in low risk prostate cancer: Role of multiparametric MRI and cancer progression predictors. Urologia. 2025:3915603251322577. doi:https:\/\/doi.org\/10.1177\/03915603251322577","DOI":"10.1177\/03915603251322577"},{"issue":"1","key":"5348_CR28","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41598-025-88392-8","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang P, Jia Z, Zheng Z, Wang J, Liang H. Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040. Sci Rep. 2025;15(1):5123. doi:https:\/\/doi.org\/10.1038\/s41598-025-88392-8","journal-title":"Sci Rep"},{"issue":"5","key":"5348_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.21614\/chirurgia.3212","volume":"120","author":"MC Ro\u015fu","year":"2025","unstructured":"Ro\u015fu MC, Ionescu CA, Enciu M, et al. Histopathological Profile of Prostatic Lesions and the Role of Gleason Score in Surgical Treatment Decision-Making. Chirurgia (Bucur). 2025;120(5):593\u2013602. doi:https:\/\/doi.org\/10.21614\/chirurgia.3212","journal-title":"Chirurgia (Bucur)"},{"issue":"5","key":"5348_CR30","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/annonc\/mdx041","volume":"28","author":"BA Mahal","year":"2017","unstructured":"Mahal BA, Chen YW, Muralidhar V, et al. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Ann Oncol. 2017;28(5):1098\u20131104. doi:https:\/\/doi.org\/10.1093\/annonc\/mdx041","journal-title":"Ann Oncol"},{"issue":"10","key":"5348_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11934-017-0724-5","volume":"18","author":"ZL Smith","year":"2017","unstructured":"Smith ZL, Eggener SE, Murphy AB. African-American Prostate Cancer Disparities. Curr Urol Rep. 2017;18(10):81. doi:https:\/\/doi.org\/10.1007\/s11934-017-0724-5","journal-title":"Curr Urol Rep"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05348-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05348-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05348-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:46:12Z","timestamp":1784609172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05348-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5348"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05348-2","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.eururo.2015.08.052","asserted-by":"subject"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}